Telapine 40/10 mg

Adult dose

The recommended dosage of this medication is 1 tablet once daily, to be taken with water regardless of meals. It is recommended to take it at the same time each day (e.g. in the morning). It can be administered in 40/5 mg, 80/5 mg, or 40/10 mg doses depending on the patient's blood pressure control status. For patients with renal impairment, it is advised to start at a lower dose for severe cases and gradually increase the dosage. For liver impairment patients, the daily dosage should not exceed

Child dose

Safety and efficacy in pediatric patients under 18 years of age have not been established, and thus, administration of this medication is not recommended.

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, and therefore should not be taken by pregnant women or women who may become pregnant. Additionally, it should not be administered to patients who are allergic to any of its components, those with severe liver or heart dysfunction, hypotensive patients, patients in cardiogenic shock, or those with unstable heart failure following acute myocardial infarction. Particular caution is required for patients with compromised liver function, obstructive biliary disease, cardiac valve diseases, gastrointestinal disorders, or renal vascular diseases when using this medication. Common side effects such as dizziness or peripheral edema may occur when taking this medication, and in severe cases, fainting may occur, so consult a healthcare professional immediately if symptoms are severe. The use of this medication should be avoided during pregnancy, and once pregnancy is confirmed, discontinuation should occur as soon as possible and replaced with safer treatment options. Given that this medication lowers blood pressure, hypotensive patients should consult a physician before taking it, and blood pressure changes should be monitored closely during treatment. The medication may increase blood potassium levels; therefore, patients at risk of hyperkalemia should undergo regular blood tests. Patients with compromised renal function may experience worsened kidney function due to this medication, necessitating periodic kidney function tests. This medication can interact with other drugs, so if currently taking other medications, be sure to inform your physician or pharmacist, especially when used in conjunction with diuretics, lithium, warfarin, or grapefruit juice. Breastfeeding women are advised not to take this medication, and caution should be exercised when driving or operating machinery as dizziness or drowsiness may occur. In case of overdose, severe hypotension, dizziness, or acute kidney failure may occur, necessitating immediate medical attention and appropriate emergency treatment. This medication has not been sufficiently confirmed for safety and efficacy in children, and therefore, its use is not recommended. Lastly, this medication should be stored out of reach of children, in its original packaging, and opened just before use.

Serious side effects

• Angioedema, urticaria, severe swelling (edema), cold sweat, pallor, severe allergic reactions
• Severe rash with fever, blisters, skin peeling, pain in oral/eye mucosa, severe skin reaction
• Difficulty breathing, respiratory distress, asthma attacks, cough with accompanying fever
• Liver dysfunction, yellowing of skin or eyes (jaundice), profound lethargy
• Sudden and very severe headache, thunderclap headache, seizures, altered consciousness

Mild side effects

• Dizziness
• peripheral edema
• upper respiratory infection
• urinary tract infection
• anemia
• hyperkalemia
• hypoglycemia
• hyponatremia
• hyperglycemia
• depression

This medication may be sensitive to light and should be stored in a container that blocks light. Additionally, to maintain the effectiveness of the medicine, it is important to store it at room temperature, between 1 to 30 degrees Celsius.

Appearance

White and light blue biconvex oval double-coated tablet

Package unit

30 tablets/box [10 tablets/PTP × 3]